Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

ADD & ADHD Health Center

Font Size

New Gene Linked to ADHD

Gene May Be Tied to Attention Deficit Hyperactivity Disorder and Response to Stimulant Drug
WebMD Health News
Reviewed by Louise Chang, MD

Feb. 16, 2010 -- A newly discovered genetic link may offer new information on the causes of attention deficit hyperactivity disorder (ADHD) as well as help determine who might best respond to treatment.

Researchers have found that a genetic variant on the latrophilin 3 gene (LPHN3) is associated with ADHD in several different populations. Previous studies have also shown that this gene plays a role in how people respond to the stimulant medications often used to treat the childhood behavioral disorder.

"It is very intriguing that the same variant (SNP marker rs6551665) associated with susceptibility to ADHD is also associated with response to stimulant medication," write researcher M. Arcos-Burgos of the National Human Genome Research Institute at the National Institutes of Health in Bethesda, Md., and colleagues in Molecular Psychiatry. "This opens a window for the evaluation of molecular substrates of ADHD and development of new drugs targeting new genes and brain pathways involved in ADHD."

Although several other genes have been linked to ADHD in previous studies, few of these linkages have been confirmed by replication in other populations.

In the study, researchers showed an association between LPHN3 in an isolated population in Colombia and then were able to replicate those results in five different populations from other areas of the world, including Germany, Norway, Spain, and the U.S.

Further brain testing results were also able to confirm this connection by showing that LPHN3 is expressed in brain regions involved in attention and activity as well as how the brain responds to ADHD stimulant medication treatment.

Researchers say the results could help identify people who are susceptible to ADHD and those who would be more likely to respond to stimulant medications as a part of their ADHD treatment.

Today on WebMD

Post it notes
Symptoms and treatments.
Close up of eye
What's zapping your focus?
man driving car
How to manage your impulses.
contemplating woman
Learn to stop procrastinating.
concentration killers
Woman taking a vitamin or supplement
ADHD and Substance Abuse
Reduce Side Effects ADHD Medications

boy eating egg
smiling man
ADHD in Marriage and Romantic Relationships
Adult man lying awake in bed